A U.S. Food and Drug Administration (FDA) advisory panel last week said that florbetapir (Amyvid), a radioactive dye proposed for use in Positron Emission Tomography (PET) to detect amyloid buildup in the brain, could be useful pending additional data analysis and training for physicians. The Alzheimer’s Association believes that further research is needed to understand the appropriate use of florbetapir-PET imaging — or any other imaging technology — in diagnosing Alzheimer’s. Read more here: http://bit.ly/huzUgV
Visit our chapter home page
Connect With Us
Copyright © 2013 Alzheimer's Association. All Rights Reserved.
Through this website you are able to link to other websites which are not under the control of the Alzheimer’s Association. We have no control over the nature, content and availability of those sites. The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.
Chapter Headquarters
Alzheimer's Association of Northern California and Northern Nevada
1060 La Avenida, Mountain View, CA 94043 Phone 650.962.8111
National Headquarters
Alzheimer's Association National Office 225 N. Michigan Ave., Fl. 17, Chicago, IL 60601 Alzheimers and Dementia Blog – Alzheimers Association of Northern California and Northern Nevada
Built on Notes Blog Core
Powered by WordPress